Trexquant Investment’s Assembly Biosciences ASMB Stock Holding History

Trexquant Investment’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Buy	45,661 +22,920	+101%	+$624K	0.01%	1385
2026 Q1	$631K	Sell	22,741 -5,535	-20%	-$158K	﹤0.01%	1391
2025 Q4	$962K	Buy	28,276 +15,750	+126%	+$507K	0.01%	1195
2025 Q3	$321K	Buy	+12,526	New	+$275K	﹤0.01%	1420
2021 Q1	–	Sell	-1,307	Closed	-$95K	–	1108
2020 Q4	$95K	Buy	+1,307	New	+$153K	0.01%	969
2018 Q2	–	Sell	-479	Closed	-$282K	–	892
2018 Q1	$282K	Buy	479 +67	+16%	+$41.5K	0.02%	831
2017 Q4	$224K	Buy	+412	New	+$186K	0.02%	883
2017 Q3	–	Sell	-875	Closed	-$217K	–	758
2017 Q2	$217K	Buy	+875	New	+$246K	0.06%	626

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Trexquant Investment's ASMB Position: Q2 2026 in Review

Trexquant Investment increased its Assembly Biosciences (ASMB) stake by 101% in Q2 2026, buying an estimated $624K and bringing the position to 45,661 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #1385.

Trexquant Investment first reported a position in ASMB in Q2 2017 and has held it in 8 quarters since. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Trexquant Investment held 45,661 shares of Assembly Biosciences worth $1.25M as of Q2 2026.
Trexquant Investment bought 22,920 Assembly Biosciences shares in Q2 2026, an estimated $624K.
Assembly Biosciences made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1385 holding.
Trexquant Investment first reported a position in Assembly Biosciences in Q2 2017 and has held it in 8 quarters since.
92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.